Rising incidence and challenges of childhood diabetes. A mini review

Journal of Endocrinological Investigation

Volumn 35, Issue 5, 2012, Pages 541-546

  Cizza, G ^a   Brown, R J ^b   Rother, K I ^b  

^a Section of Neuroendocrinology of Obesity   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autoimmunity; Chronic stress; Genetic; Leptin; Obesity; Prevention; Sleep deprivation; Socioeconomic status; Vitamin D

Indexed keywords

GLUCOSE; LEPTIN; METFORMIN; PRAMLINTIDE;

AUTOIMMUNITY; BARIATRIC SURGERY; CHILDHOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SHORT SURVEY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

ADOLESCENT; CHILD; DIABETES MELLITUS; HUMANS; INCIDENCE; UNITED STATES;

EID: 84863937073     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8411     Document Type: Short Survey

References (62)

1. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005, 146: 693-700. (Pubitemid 40616257)
2. Klingensmith GJ, Pyle L, Arslanian S, et al TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010, 33: 1970-5.
3. rd, Hirshberg B, et al. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia 2009, 52: 1369-80.
4. Rother KI, Spain LM, Wesley RA, et al. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care 2009, 32: 2251-7.
5. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008, 371: 1777-82. (Pubitemid 351697953)
6. Brown RJ, Rother KI. Type 1 and Type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Curr Cardiovasc Risk Rep 2010, 4: 175-7.
7. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005- 20: a multicentre prospective registration study. Lancet 2009, 373: 2027-33.
8. Dabelea D, Mayer-Davis EJ, Imperatore G. The value of national diabetes registries: SEARCH for Diabetes in Youth Study. Curr Diab Rep 2010, 10: 362-9.
9. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006, 23: 857-66.
10. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 2010, 33: 2573-9.
11. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010, 39: 419-46.
12. Borkar VV, Devidayal, Verma S, Bhalla AK. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes 2010, 11: 345-50.
13. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994, 37: 552-8. (Pubitemid 24162425)
14. Del Pino-Montes J, Benito GE, Fernández-Salazar MP, et al. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int 2004, 75: 526-32. (Pubitemid 40174512)
15. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes (Lond) 2009, 33: 716-26.
16. Kharagjitsingh A, de Ridder M, Alizadeh B, et al. Genetic correlates of early accelerated infant growth associated with juvenile-onset type 1 diabetes. Pediatr Diabetes 2011, 13: 266-71.
17. Verbeeten KC, Elks CE, Daneman D, Ong KK. Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med 2011, 28: 10-8.
18. Knip M, Reunanen A, Virtanen SM, Nuutinen M, Viikari J, Akerblom HK. Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes? Pediatr Diabetes 2008, 9: 46-9. (Pubitemid 351784994)
19. Knerr I, Wolf J, Reinehr T, et al DPV Scientific Initiative of Germany and Austria. The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005, 48: 2501-4. (Pubitemid 41738214)
20. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007, 30: 2314-20. (Pubitemid 47359040)
21. D'Angeli MA, Merzon E, Valbuena LF, Tirschwell D, Paris CA, Mueller BA. Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and over-load hypotheses. Arch Pediatr Adolesc Med 2010, 164: 732-8.
22. Gerrard JW, Geddes CA, Reggin PL, Gerrard CD, Horne S. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976, 37: 91-100.
23. Björkstén B. The hygiene hypothesis: do we still believe in it? Nestle Nutr Workshop Ser Pediatr Program 2009, 64: 11-8; discussion 18-22, 251-7.
24. Neu J, Lorca G, Kingma SD, Triplett EW. The intestinal microbiome: relationship to type 1 diabetes. Endocrinol Metab Clin North Am 2010, 39: 563-71.
25. Knip M, Virtanen SM, Seppä K, et al Finnish TRIGR Study Group. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010, 363: 1900-8.
26. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010, 6: 279-89.
27. Knip M. Descriptive epidemiology of type 1 diabetes-is it still in? Diabetologia 2012, 55: 1227-30.
28. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2012, 8: 228-36.
29. Gemmill JA, Brown RJ, Nandagopal R, Rodriguez LM, Rother KI. Clinical trials in youth with type 2 diabetes. Pediatr Diabetes 2011, 12: 50-7.
30. TODAY Study Group; Zeitler P, Epstein L, Grey M, et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007, 8: 74-87.
31. Bogardus C, Tataranni PA. Reduced early insulin secretion in the etiology of type 2 diabetes mellitus in Pima Indians. Diabetes 2002, 51 (Suppl 1): S262-4. (Pubitemid 34761526)
32. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005, 28: 638-44.
33. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010, 363: 2339-50.
34. Copeland KC, Zeitler P, Geffner M, et al TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011, 96: 159-67.
35. Smith J, Cianflone K, Biron S, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 2009, 94: 4275-83.
36. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993, 16: 310-4. (Pubitemid 23013867)
37. Pinney SE, Simmons RA. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab 2010, 21: 223-9.
38. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011, 62: 361-80.
39. Tsaoussoglou M, Bixler EO, Calhoun S, Chrousos GP, Sauder K, Vgontzas AN. Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. J Clin Endocrinol Metab 2010, 95: 143-50.
40. Low JC, Felner EI, Muir AB, et al. Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes? Prim Care Diabetes. 2012, 6: 61-5.
41. Gosmanov AR, Smiley D, Robalino G, et al. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Diabetes Care 2010, 33: 854-60.
42. Pozzilli P, Buzzetti R. A new expression of diabetes: double diabetes. Trends Endocrinol Metab 2007, 18: 52-7. (Pubitemid 46290695)
43. Bosnyak Z, Nishimura R, Hagan Hughes M, et al. Excess mortality in Black compared with White patients with Type 1 diabetes: an examination of underlying causes. Diabet Med 2005, 22: 1636-41. (Pubitemid 43046462)
44. Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M. Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Cardiovasc Prev Rehabil 2011, April 28 [Epub ahead of print]; doi: 10.1177/1741826711409324.
45. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 2009, 52: 65-73.
46. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-59.
47. van Vliet M, Van der Heyden JC, Diamant M, et al. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 2010, 156: 923-9.
48. Schauer IE, Snell-Bergeon JK, Bergman BC, et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes 2011, 60: 306-14.
49. Draznin B. Mitogenic action of insulin: friend, foe or 'frenemy'? Diabetologia 2010, 53: 229-33.
50. Flint A, Arslanian S. Treatment of type 2 diabetes in youth. Diabetes Care 2011, 34 (Suppl 2): S177-83.
51. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A 2010, 107: 4813-9.
52. Mittendorfer B, Horowitz JF, DePaoli AM, McCamish MA, Patterson BW, Klein S. Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes. Diabetes 2011, 60: 1474-7.
53. Beltrand J, Lahlou N, Le Charpentier T, et al. Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin. Eur J Endocrinol 2010, 162: 1083-91.
54. Amylin. r-MetHu leptin (A-100) Investigator's Brochure.
55. Rother KI, Brown RJ, Morales MM, et al. Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes. Diabetes Care 2009, 32: 1250-5.
56. MacroGenics Inc, Eli Lilly and Company. MacroGenics and Lilly announce pivotal clinical trial of teplizumab did not meet primary efficacy endpoint. Oct 20, 2010. Available at: http://newsroom.lilly.com/releasedetail.cfm?releaseid= 521014.
57. Diamyd Medical. Diamyd reports initial results from European Phase III trial in patients newly diagnosed with type 1 diabetes. May 9, 2011. Available at: http://www.cisionwire.com/diamyd-medical/r/diamyd-reports-initial-results- from-european-phase-iii-trialin-patients-newly-diagnosed-with-type-1-diabetes, c9117770.
58. Brandt ML, Harmon CM, Helmrath MA, Inge TH, McKay SV, Michalsky MP. Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. Nat Rev Endocrinol 2010, 6: 637-45.
59. Nandagopal R, Brown RJ, Rother KI. Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther 2010, 12: 671-7.
60. Inge TH, Zeller M, Harmon C, et al. Teen-Longitudinal Assessment of Bariatric Surgery: methodological features of the first prospective multicenter study of adolescent bariatric surgery. J Pediatr Surg 2007, 42: 1969-71. (Pubitemid 350088864)
61. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010, 33: 1004-8.
62. Reinehr T, Schober E, Roth CL, Wiegand S, Holl R; DPV-Wiss Study Group. Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res 2008, 69: 107-13.